**Core Concept**
OCPs (Oral Contraceptive Pills) are a form of hormonal contraception that combines estrogen and progestin to prevent ovulation. However, they can have adverse effects on certain medical conditions, making them contraindicated in specific situations.

**Why the Correct Answer is Right**
The correct answer is D. All of the above because OCPs are contraindicated in conditions where they can exacerbate or worsen the underlying pathology. In heart disease (A), estrogen can increase the risk of thromboembolic events and worsen cardiovascular outcomes. In thromboembolism (B), the presence of estrogen can further increase the risk of blood clots. In breast cancer (C), the estrogen component of OCPs can stimulate the growth of hormone receptor-positive tumors. Therefore, OCPs are generally avoided in these conditions.

**Why Each Wrong Option is Incorrect**
**Option A:** Heart disease is not an absolute contraindication for OCPs, but rather a relative contraindication. Women with heart disease may still use OCPs, but with caution and under close monitoring.

**Option B:** Thromboembolism is a significant contraindication for OCPs, but it is not the only correct answer. The correct answer is an inclusive option (D) that encompasses all the conditions listed.

**Clinical Pearl / High-Yield Fact**
When considering OCPs in patients with medical conditions, it's essential to weigh the benefits of contraception against the potential risks. A thorough medical history and risk assessment are crucial in making informed decisions.

**Correct Answer Line**
✓ Correct Answer: D. All of the above